use of ritonavir (abbot 538) for improving the pharmacokinetics of drugs that are metabolised by cytochrome p450, in the context of treatment of aids

摘要

There is described a combination of ritonavir or a pharmaceutically acceptable salt thereof in combination with another HIV protease inhibitor, formulated as a single or separate composition, for use in the inhibition or treatment of an HIV infection or AIDS in a human host.